Project Grant R21NS140782

Award Date 12/1/24
Completion Date 11/30/26
Dollars Obligated $246K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Albany, NY 12208, USA
Similar Awards
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) provides $608,899.00 to the Regents of the University of California at Riverside to study the role of astrocytic volume-regulated anion channels (VRACs) in regulating brain tissue excitability, seizure generation, and epilepsy development. The research aims to determine how astrocytic VRAC...
This $296,108 Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders will support research at the Scripps Research Institute to investigate how mechanosensation at the choroid plexus contributes to intracranial pressure (ICP) regulation in health and disease. The project aims to characterize the role of the mechanosensitive ion channel Piezo1 in choroid plexus...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to understand the function of the small conductance calcium-activated potassium (SK2) channel in astrocytes and its interaction with adrenergic signaling. The total funding amount is $433,125.00, with a project period from June 23, 2025 to May 31, 2027. The...
This federal Project Grant award of $565,257.00 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant supports research to understand how presynaptic modulation of synaptic inhibition onto hippocampal pyramidal neurons in the brain regulates spatial information encoding. Key objectives include determining how metabotropic glutamate receptor...
This federal Project Grant award of $290,688 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award will fund research at Brandeis University to investigate the role of neuronal primary ciliary signaling in regulating the balance of excitation and inhibition in the neocortex. The research will focus on somatostatin receptor 3 (SSTR3) signaling in...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $361,975 to support research focused on developing chemical strategies for imaging and manipulating astrocytes in the brain. The project aims to expand the capabilities of an astrocyte-targeting chemical tag to enable direct visualization and modulation of astrocyte...
This $412,500 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders federal grant program (CFDA 93.853), supports research conducted by Louisiana State University Health Sciences Center New Orleans. The research aims to define the roles of the protein Coracle in regulating the dynamics of active zones - specialized structures in nerve terminals that control...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under CFDA 93.310 - Trans-NIH Research Support program totals $1,490,348 and is aimed at testing an integrative hypothesis about the role of astrocytes in the brain's neuromodulator signaling systems. The award, made to the Research Foundation For Mental Hygiene, Inc. (RFMH) doing business as the New York Psychiatric Center, will utilize state-of-the-art cellular imaging and spatial transcriptomics...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $376,355 to Albany Medical College to study the role of microglial insulin-like growth factor 1 (IGF1) in epileptogenesis. The research aims to characterize how elevated mTOR signaling in microglia leads to increased IGF1 expression, and how this propagates mTOR signaling to...
This federal Project Grant award of $107,948 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research to investigate the relationship between extracellular citrate levels and neuronal excitability in a genetic form of epilepsy known as SLC13A5 epilepsy. The principal investigator will use advanced imaging, electrophysiology, and mass spectrometry techniques in...

This federal Project Grant award, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to investigate the role of LRRC8 anion channels in brain taurine signaling and body fluid homeostasis. The $245,938 award, effective from December 1, 2024 to November 30, 2026, will be conducted by Albany Medical College. The research aims to conclusively demonstrate the contribution of LRRC8A-containing volume-regulated anion channels (VRACs) to the regulation of extracellular taurine and GABA levels in the mammalian brain, as well as ascertain the functional role of astrocytic VRAC-mediated taurine release in hypothalamic control of body fluid-electrolyte homeostasis. This exploratory study seeks to address a significant gap in knowledge regarding the role of brain LRRC8/VRAC channels in the negative control of neuronal excitability, which is important for developing neuroprotective agents targeting VRAC activity in stroke and other brain pathologies.

Generated 8/5/25, 5:49 AM